Printer Friendly
The Free Library
14,757,006 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amersham Biosciences Launches Versatile Sub-Cellular Imaging System.


Business Editors/Health/Medical Writers

BIOWIRE2K

PISCATAWAY, N.J.--(BUSINESS WIRE)--July 28, 2003

IN Cell Analyzer 1000 offers integrated solutions for

medium throughput cell-based drug profiling, target validation

and assay development

Amersham Biosciences, the life sciences business of Amersham (NYSE NYSE

See: New York Stock Exchange
:AHM AHM Automated Hacking Machines
AHM All Hands Meeting
AHM Academy for Healthcare Management
AHM Atom Heart Mother (Pink Floyd album)
AHM Airport Handling Manual
AHM Acutely Hazardous Material
AHM Anti-Helicopter Mine
) (LSE LSE - Language Sensitive Editor :AHM) (OSE OSE - Open Systems Environment :AHM), today announced the availability of IN Cell Analyzer 1000. The modular image analysis platform provides a flexible system to address a range of biological applications in drug discovery.

Scientists in pharma, biotechs and academia with medium throughput requirements can use the adaptable IN Cell Analyzer 1000 for screening, lead profiling, target validation and assay development. This modular sub-cellular imaging system can be used to observe live cells in culture for responses to potential drug compounds to ascertain whether the compounds will be effective as drugs or toxic to cells or to delineate gene function.

IN Cell Analyzer 1000 can also be used as an assay development station to the IN Cell Analyzer 3000, Amersham Biosciences' high throughput, high content sub-cellular imaging and analysis system, to provide a complete system for screening, lead profiling and target validation in drug discovery. By analyzing real-time events in live cells, the IN Cell Analyzer platform gives more biologically relevant information which is a pre-requisite to understanding functional biology and the role genes and proteins play in the cause of disease.

IN Cell Analyzer 1000 is part of an integrated system comprising instrumentation, assays, algorithms and software. Its open architecture enables scientists to use a variety of automation options. The platform is compatible with a variety of assay formats, including fluorescence-, bright field-, and luminescence-based assays. Advanced analysis software included with IN Cell Analyzer 1000 has been designed to address specific assays with validated analysis modules for automated operations. To complement the IN Cell Analyzer 1000 and 3000 platforms, Amersham Biosciences is developing a comprehensive panel of profiling assays for a planned launch in 2004.

"IN Cell Analyzer 1000 is an extremely flexible platform that meets a range of biological applications from basic research through to medium throughput screening, and will be of particular use in lead profiling and target validation," comments Cathy Howat, Vice President Marketing Cell Analysis and Screening, Discovery Systems at Amersham Biosciences. "It is ideally suited for rapid image acquisition and analysis for cell-based assays. In high throughput environments, IN Cell Analyzer 1000 can be used easily as a multipurpose mul·ti·pur·pose  
adj.
Designed or used for several purposes: a multipurpose room; multipurpose software.


multipurpose
Adjective
 assay development station, accommodating a variety of assay formats."

The system's open design provides users with complete flexibility in dye choice, automation linking and image analysis. In addition, the modular design In the context of systems engineering, modular design — or "modularity in design" — is an approach aiming to subdivide a system into smaller parts (modules) that can be independently created and then used in different systems to drive multiple functionalities.  of IN Cell Analyzer 1000 will facilitate easy system upgrades to enable an extended range of live and fixed cell-based assays to be performed. IN Cell Analyzer 1000 comprises a Nikon(TM) microscope, high-resolution CCD camera See digital camera. , quality optics, laser auto-focus, and a motorized mo·tor·ize  
tr.v. mo·tor·ized, mo·tor·iz·ing, mo·tor·iz·es
1. To equip with a motor.

2. To supply with motor-driven vehicles.

3. To provide with automobiles.
 stage.

IN Cell Analyzer 1000 is covered by Amersham Biosciences' wide range of global customer support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services  delivered by Labcrew(TM).

Amersham Biosciences, the life sciences business of Amersham plc Amersham plc was a UK pharmaceutical company, specializing in medical diagnostics and life science products.

The company was formed in 1997 by merging Amersham International (U.K.), Pharmacia Biotech (Sweden) and Nycomed (Norway).
 (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technology are pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
 and research and academic institutions, principally in North America, Europe, Latin America and Asia. More information about Amersham Biosciences is available at www.amershambiosciences.com.

Amersham Biosciences - enabling molecular medicine
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUUK
Date:Jul 28, 2003
Words:590
Previous Article:Tvia, Inc. Reports Results for Quarter Ended June 30, 2003.
Next Article:Hilton Reports 2003 Second Quarter, Six-Month Results.
Topics:



Related Articles
Subcellular life in the fast lane. (transportation within nerve cells)
X rays yield sharp, microscopic 3-D images. (ultra-high-resolution X-ray tomography used to image cells in three dimensions) (Brief Article)
Novel Imaging Technologies "Illuminate" Environmental Health Science Research.
Amersham Biosciences' IN Cell Analyzer Delivers Outstanding Results for AstraZeneca.
Amersham Biosciences Launches IN Cell Analyzer 3000; High-Throughput Imaging System Enables Direct Analysis of Drug Activity at the Cellular Level.
Amersham Biosciences Introduces LEADseeker Multimodality Imaging System.
Norak Biosciences Purchases Second IN Cell Analyzer 3000 from Amersham Biosciences.
Amersham Biosciences and GeneBio Expand Alliance to Develop Next Generation Proteomics Image Analysis Software.
Lilly Complements its Drug Discovery Research with Integrated Cellular Screening System from Amersham Biosciences.
Circulating cells in cancer detection.(Fellowships, Grants & Awards)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles